Literature DB >> 29395706

Epidemiology of Kawasaki Disease in Canada 2004 to 2014: Comparison of Surveillance Using Administrative Data vs Periodic Medical Record Review.

Cedric Manlhiot1, Sunita O'Shea1, Bailey Bernknopf1, Michael LaBelle1, Nita Chahal1, Rejane F Dillenburg2, Lillian S Lai3, Dirk Bock4, Brendan Lew1, Sameer Masood1, Mathew Mathew1, Brian W McCrindle5.   

Abstract

BACKGROUND: We have previously documented an increase in the incidence of Kawasaki disease (KD) in Ontario followed by a stabilization from 1995 to 2006. We sought to validate the estimation of incidence of KD using administrative data and to describe the epidemiology of KD across Canada from 2004 to 2014.
METHODS: We queried the Canadian Hospital Discharge Database for hospital admissions associated with a discharge diagnosis of KD. The data set was manually curated and estimates of incidence were compared with those obtained from the retrospective triennial surveillances of KD performed in 2007 and 2010.
RESULTS: The average number of cases per year identified through administrative data was 245 ± 45 vs 229 ± 33 from retrospective surveillance. This overestimation, representing 7 ± 6%, is similar to the historical percentage of patients originally diagnosed with KD in whom the diagnosis is subsequently excluded. The annual incidence of KD in Canada was 19.6, 6.4, and 1.3 cases per 100,000 children younger than 5 years, 5-9 years, and 10-14 years old, respectively, with important regional and seasonal differences. The incidence remained stable over the study period in the youngest age group but increased in both older age categories. Coronary artery aneurysms affected 3.5% of all patients, and 0.8% experienced associated major cardiac complications.
CONCLUSIONS: Reliance on administrative data to determine incidence of KD is feasible and accurate with manual curation of the data. The incidence of KD in Canada seems to have plateaued for younger children. Differences in annual incidence observed between provinces remain to be explained, and might reflect genetic or environmental differences.
Copyright © 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29395706     DOI: 10.1016/j.cjca.2017.12.009

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  10 in total

1.  Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort study.

Authors:  Stephen G Fung; Richard Webster; M Ellen Kuenzig; Braden D Knight; Michelle Batthish; Cal Robinson; Rahul Chanchlani; Eric I Benchimol; Carolina Jimenez-Rivera
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

2.  Health care utilization and costs following Kawasaki disease.

Authors:  Cal Robinson; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Hsien Seow; Michelle Batthish
Journal:  Paediatr Child Health       Date:  2022-03-01       Impact factor: 2.600

3.  Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada.

Authors:  Cal Robinson; Megan Schlorff; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Tapas Mondal; Hsien Seow; Michelle Batthish
Journal:  Pediatr Cardiol       Date:  2022-09-08       Impact factor: 1.838

4.  Spatiotemporal clustering of cases of Kawasaki disease and associated coronary artery aneurysms in Canada.

Authors:  Jason Hearn; Brian W McCrindle; Brigitte Mueller; Sunita O'Shea; Bailey Bernknopf; Michael Labelle; Cedric Manlhiot
Journal:  Sci Rep       Date:  2018-12-05       Impact factor: 4.379

5.  Association between Kawasaki Disease and Prenatal Exposure to Ambient and Industrial Air Pollution: A Population-Based Cohort Study.

Authors:  Stephane Buteau; Sabrina Belkaibech; Marianne Bilodeau-Bertrand; Marianne Hatzopoulou; Audrey Smargiassi; Nathalie Auger
Journal:  Environ Health Perspect       Date:  2020-10-19       Impact factor: 9.031

Review 6.  Global epidemiology of vasculitis.

Authors:  Richard A Watts; Gulen Hatemi; Jane C Burns; Aladdin J Mohammad
Journal:  Nat Rev Rheumatol       Date:  2021-12-01       Impact factor: 20.543

Review 7.  Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.

Authors:  Wendy Lee; Chooi San Cheah; Siti Aisyah Suhaini; Abdullah Harith Azidin; Mohammad Shukri Khoo; Noor Akmal Shareela Ismail; Adli Ali
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

8.  Associations between the spatiotemporal distribution of Kawasaki disease and environmental factors: evidence supporting a multifactorial etiologic model.

Authors:  Brian W McCrindle; Cedric Manlhiot; Tisiana Low; Brigitte Mueller; Chun-Po S Fan; Emily Somerset; Sunita O'Shea; Leonard J S Tsuji; Hong Chen
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

9.  Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.

Authors:  Li-Ping Xie; Wei-Li Yan; Min Huang; Mei-Rong Huang; Sun Chen; Guo-Ying Huang; Fang Liu
Journal:  J Epidemiol       Date:  2019-09-21       Impact factor: 3.211

Review 10.  Incorporating Risk Stratification Into the Practice of Pediatric Preventive Cardiology.

Authors:  Michael Khoury; Rae-Ellen W Kavey; Julie St Pierre; Brian W McCrindle
Journal:  Can J Cardiol       Date:  2020-07-14       Impact factor: 5.223

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.